Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPO.L Regulatory News (SPO)

  • There is currently no data for SPO

Refinancing to support Strategic Objectives

19 Jul 2012 07:00

RNS Number : 9876H
Sportech PLC
19 July 2012
Ā 

Sportech PLC ("Sportech" or "the Group")

Ā 

Sportech secures refinancing to

support strategic objectives

Ā 

Key highlights

Ā 

Ā·; New multi bank facilities to provide debt refinancing

Ā·; Banking relationships strengthened with new multi bank structure replacing single bank arrangement

Ā·; Overall size of facilities increased by 25% to support growth of the business

Ā·; New arrangements provide flexible financial covenants

Ā 

Sportech Plc is pleased to announce that it has signed new banking facilities with immediate effect.

Ā 

The Group has entered into a new £75 million, multi currency revolving credit facility, to include up to £5m of ancillary working capital facilities across key trading jurisdictions, provided by Bank of Scotland Plc, Barclays Bank Plc and The Royal Bank of Scotland Plc (the "Facility").

Ā 

The Facility has an initial debt maturity date of 31 August 2015, which is able to be extended at the Group's request, with the agreement of the lenders, for a further 12 month period.

Ā 

The Facility replaces the Group's previous amortising loan facilities provided solely by the Bank of Scotland Plc, which were due to expire in July 2013 and consisted at the time of refinancing of a £55.5m term loan and a £3m UK working capital facility.

Ā 

Within the terms of the Facility, the Group believes it has operational flexibility to implement its medium term plans. Financial covenants provide increased flexibility with consolidated total net borrowings to adjusted EBITDA ("leverage") required to be no higher than 2.75x for testing periods through to March 2014, then reducing to a maximum of 2.50x through to March 2015 and thereafter a test level of a maximum 2.25x. The Group's borrowing costs will be dependent on the ongoing level of leverage with a debt margin payable of between 250 and 375 basis points per annum. Commitment fees will also apply at normal commercial rates. An arrangement fee of 1.75% is payable at the outset of the Facility which will be expensed during 2012 along with associated refinancing, legal and debt advisory fees.

Ā 

Of particular note, the Group has secured agreement with the lenders that the Facility will remain in place in its entirety should the Group be ultimately successful in its ongoing Spot the Ball VAT claim against HM Revenue & Customs, due to be heard at the First Tier Tax Tribunal in October of this year.

Ā 

As a related point to the refinancing, the Group's existing interest rate swaps will no longer remain eligible for hedge accounting under International Financial Reporting Standards following the refinancing. Accordingly, in the second half of the Company's financial year ending 31 December 2012, the existing mark-to-market exposures of the interest rate swaps will be required to be applied to the income statement. At the date of this announcement, the mark-to-market exposures under the interest rate swaps, which it is noted are entirely of a non-cash nature, are approximately £3.3 million.

Ā 

For further information contact:

Ā 

Sportech PLC

020 7268 2400

Ian Penrose, Chief Executive

Steve Cunliffe, Finance Director

Pelham Bell Pottinger

020 78613232

David Rydell

Emma Kent

Rosanne Perry

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
MSCEVLFFLDFFBBD
Date   Source Headline
17th Oct 20237:00 amRNSCancellation - Sportech PLC
16th Oct 20237:00 amRNSMatched Bargain Dealing Facility
13th Oct 20233:31 pmRNSHolding(s) in Company
12th Oct 20235:45 pmRNSSportech
9th Oct 20232:17 pmRNSHolding(s) in Company
5th Oct 202310:00 amRNSResult of General Meeting
28th Sep 202311:50 amRNSDirector/PDMR Shareholding
28th Sep 202310:03 amRNSHolding(s) in Company
28th Sep 20239:55 amRNSHolding(s) in Company
27th Sep 20234:00 pmRNSDirector/PDMR Shareholding
25th Sep 202312:21 pmRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSHolding(s) in Company
19th Sep 20237:00 amRNSPublication of Circular and Notice of GM
14th Sep 20237:00 amRNSNotification of Major Holdings
11th Sep 20237:01 amRNSProposed De-lisiting
11th Sep 20237:00 amRNSHalf-year Report
30th Aug 20232:02 pmRNSNotification of Major Holdings
27th Jul 20231:35 pmRNSCapital distribution dates
24th Jul 20235:25 pmRNSTotal Voting Rights and Distribution
19th Jul 202312:00 pmRNSResult of Meeting
28th Jun 20237:00 amRNSPosting of Circular, Notice of GM and Distribution
26th Jun 20237:00 amRNSShare Restructure, Distribution and GM
30th May 20235:48 pmRNSResult of AGM
30th May 20237:00 amRNSAGM Trading Update
5th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSFinal Results
28th Feb 20233:34 pmRNSNotification of Major Holdings
24th Jan 20237:35 amRNSFY 2022 pre-close update
4th Jan 20234:13 pmRNSNotification of Major Holdings
24th Oct 20228:30 amRNSDirector/PDMR Shareholding
17th Oct 20227:00 amRNSNotification of Major Holings
17th Oct 20227:00 amRNSNotification of Major Holdings
14th Oct 20229:44 amRNSNotification of Major Holdings
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20224:41 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension
1st Sep 20227:00 amRNSInterim Results
24th Aug 20227:00 amRNSDirectorate Change
28th Jul 20227:00 amRNSDirectorate Change
31st May 20222:00 pmRNSResult of Annual General Meeting
31st May 20227:00 amRNSAGM Trading Update and Board Changes
25th May 20227:00 amRNSDirectorate Change
6th May 20227:00 amRNSNotice of Annual General Meeting
27th Apr 20227:00 amRNSStatement re Capital Distribution to Shareholders
14th Apr 20227:00 amRNSDirectorate Change
1st Apr 20227:00 amRNSDirectorate Changes
31st Mar 20227:00 amRNSFinal Results
22nd Mar 20221:42 pmRNSNotification of Major Holdings
22nd Mar 202211:09 amRNSNotification of Major Holdings
15th Mar 20224:46 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.